Cigna Corporation provides insurance and related products and services in the United States. Its Evernorth segment provides a range of coordinated and point solution health services, including pharmacy, benefits management, care, and intelligence solutions to health plans, employers, government organizations, and health care providers. The company's U.S. Medical segment offers commercial products and services, including medical, pharmacy, behavioral health, dental, vision, health advocacy programs, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as Medicaid plans; and individual health insurance plans to on and off the public exchanges. Its International Markets segment offers health coverage, hospitalization, dental, critical illness, personal accident, term life, medical cost containment, and variable universal life products, as well as health care benefits to mobile employees of multinational organizations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
IPO Year:
Exchange: NYSE
Website: cigna.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/6/2025 | $323.00 | Outperform → Mkt Perform | Bernstein |
| 6/26/2024 | $400.00 | Overweight | Piper Sandler |
| 5/30/2024 | $388.00 | Outperform | Robert W. Baird |
| 3/6/2024 | $393.00 | Overweight | Barclays |
| 2/5/2024 | $334.00 → $372.00 | Neutral → Overweight | Cantor Fitzgerald |
| 2/5/2024 | $327.00 → $354.00 | Sector Perform → Outperform | RBC Capital Mkts |
| 2/1/2024 | $355.00 → $370.00 | Hold → Buy | Deutsche Bank |
| 1/4/2024 | $330.00 → $372.00 | Mkt Perform → Outperform | Bernstein |
| 12/11/2023 | $335.00 → $341.00 | Hold → Buy | Jefferies |
| 8/18/2023 | Buy → Hold | Edward Jones |
Total revenues for the first quarter 2025 increased 14% to $65.5 billionShareholders' net income for the first quarter 2025 was $1.3 billion, or $4.85 per shareAdjusted income from operations1 for the first quarter 2025 was $1.8 billion, or $6.74 per share2025 adjusted income from operations1,2 increased to at least $29.60 per share2BLOOMFIELD, Conn., May 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong first quarter 2025 results, reflecting growth and focused execution across its diversified portfolio of businesses. "We are buildin
BLOOMFIELD, Conn., April 23, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.51 per share of its common stock, payable on June 18, 2025 to shareholders of record as of the close of business on June 3, 2025. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services m
AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a+" (Excellent) of the key U.S. life/health subsidiaries and Europe-based insurance companies of The Cigna Group (Cigna) (headquartered in Bloomfield, CT) (NYSE:CI). In addition, AM Best has affirmed the Long-Term ICR of "bbb+" (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of Cigna. AM Best also has affirmed the Short-Term Issue Credit Rating (Short-Term IR) of Cigna. The outlook of these Credit Ratings (ratings) is stable. (Please see below for a detailed listing of the companies and ratings.) The majority of Cigna's core U.S. health insuran
BLOOMFIELD, Conn., April 4, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its first quarter 2025 financial results on Friday, May 2, 2025, and will host a conference call the same day. First quarter 2025 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call(888) 566-1889 (Domestic)(773) 799-3989 (International)Passcode: 05022025 Replay(800) 835-8067 (Domestic)(203) 369-3354 (International)
Brian Evanko named President and Chief Operating Officer, The Cigna GroupAnn Dennison named Executive Vice President and Chief Financial Officer, The Cigna GroupNicole Jones, Chief Administrative Officer and General Counsel, to assume oversight of Enterprise MarketingEric Palmer, President and Chief Executive Officer of Evernorth Health Services, to depart The Cigna GroupReaffirms Full Year 2025 Financial Outlook BLOOMFIELD, Conn., March 13, 2025 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to further drive the company's focus on customers and patients and accelerate its growth strategy.
Total revenues for 2024 increased 27% to $247.1 billionShareholders' net income for 2024 was $3.4 billion, or $12.12 per shareAdjusted income from operations1 for 2024 was $7.7 billion, or $27.33 per share2025 adjusted income from operations1,2 is projected to be at least $7.9 billion, or at least $29.50 per shareBoard of Directors declared an 8% increase in the quarterly dividend to $1.51 per share and approved an increase of $6.0 billion in incremental share repurchase authorization, bringing total authorization to $10.3 billionBLOOMFIELD, Conn., Jan. 30, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported 2024 results, reflecting continued strength in Ever
BLOOMFIELD, Conn., Jan. 14, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2024 financial results on Thursday, January 30, 2025, and will host a conference call the same day. Fourth quarter 2024 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call(888) 566-1889 (Domestic)(773) 799-3989 (International)Passcode: 01302025 Replay(800) 819-5739 (Domestic)(203) 369-3350 (Inter
Total revenues for the third quarter 2024 increased 30% to $63.7 billionShareholders' net income for the third quarter 2024 was $0.7 billion, or $2.63 per shareAdjusted income from operations1 for the third quarter 2024 was $2.1 billion, or $7.51 per shareReaffirms 2024 outlook2 for adjusted income from operations1,2 of at least $28.40 per shareBLOOMFIELD, Conn., Oct. 31, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong third quarter 2024 results demonstrating focused execution across Evernorth Health Services and Cigna Healthcare. "Ou
BLOOMFIELD, Conn., Oct. 23, 2024 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.40 per share of its common stock, payable on December 19, 2024 to shareholders of record as of the close of business on December 4, 2024. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and serv
BLOOMFIELD, Conn., Oct. 3, 2024 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its third quarter 2024 financial results on Thursday, October 31, 2024, and will host a conference call the same day. Third quarter 2024 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call (888) 566-1889 (Domestic) (773) 799-3989 (International) Passcode: 103
Total revenues for the first quarter 2025 increased 14% to $65.5 billionShareholders' net income for the first quarter 2025 was $1.3 billion, or $4.85 per shareAdjusted income from operations1 for the first quarter 2025 was $1.8 billion, or $6.74 per share2025 adjusted income from operations1,2 increased to at least $29.60 per share2BLOOMFIELD, Conn., May 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported strong first quarter 2025 results, reflecting growth and focused execution across its diversified portfolio of businesses. "We are buildin
BLOOMFIELD, Conn., April 23, 2025 /PRNewswire/ -- The Board of Directors of The Cigna Group (NYSE:CI) today declared a cash dividend of $1.51 per share of its common stock, payable on June 18, 2025 to shareholders of record as of the close of business on June 3, 2025. About The Cigna Group The Cigna Group (NYSE:CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services m
BLOOMFIELD, Conn., April 22, 2025 /PRNewswire/ -- As part of The Cigna Group's (NYSE:CI) multiyear commitment to improve youth mental health, The Cigna Group Foundation announced a $1 million contribution over the next two years to Boys & Girls Clubs of America. Boys & Girls Clubs of America will use the funding to expand its work with local Clubs to train staff on how to identify the signs and symptoms of youth in distress, and become trauma-informed in their policies, practices, and programs, and expand the use of its successful Behavioral Support Toolkit to all Clubs. "As a
BLOOMFIELD, Conn., April 10, 2025 /PRNewswire/ -- In an effort to aid local communities impacted by the Southern California wildfires, The Cigna Group and basketball legend Earvin "Magic" Johnson joined forces on a Bright Futures Carnival that provided Boys & Girls Club of Pasadena kids with a fun-filled day of activities, food and gifts – along with a special visit from the basketball legend himself. The local Pasadena, Calif. community, as well as other areas, experienced devastating losses due to the fires. In all, 75 families from the Boys & Girls Club of Pasadena lost the
AM Best has affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term Issuer Credit Ratings (Long-Term ICRs) of "a+" (Excellent) of the key U.S. life/health subsidiaries and Europe-based insurance companies of The Cigna Group (Cigna) (headquartered in Bloomfield, CT) (NYSE:CI). In addition, AM Best has affirmed the Long-Term ICR of "bbb+" (Good) and the Long-Term Issue Credit Ratings (Long-Term IRs) of Cigna. AM Best also has affirmed the Short-Term Issue Credit Rating (Short-Term IR) of Cigna. The outlook of these Credit Ratings (ratings) is stable. (Please see below for a detailed listing of the companies and ratings.) The majority of Cigna's core U.S. health insuran
BLOOMFIELD, Conn., April 4, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its first quarter 2025 financial results on Friday, May 2, 2025, and will host a conference call the same day. First quarter 2025 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call(888) 566-1889 (Domestic)(773) 799-3989 (International)Passcode: 05022025 Replay(800) 835-8067 (Domestic)(203) 369-3354 (International)
BLOOMFIELD, Conn., March 19, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today announced the successful completion of the sale of its Medicare Advantage, Cigna Supplemental Benefits, Medicare Part D, and CareAllies businesses to Health Care Service Corporation (HCSC). The divestment of these assets streamlines The Cigna Group's portfolio and enables it to drive further innovation to support customers. As previously announced, proceeds from the sale will be used in alignment with The Cigna Group's capital deployment priorities, with the majority expecte
Brian Evanko named President and Chief Operating Officer, The Cigna GroupAnn Dennison named Executive Vice President and Chief Financial Officer, The Cigna GroupNicole Jones, Chief Administrative Officer and General Counsel, to assume oversight of Enterprise MarketingEric Palmer, President and Chief Executive Officer of Evernorth Health Services, to depart The Cigna GroupReaffirms Full Year 2025 Financial Outlook BLOOMFIELD, Conn., March 13, 2025 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to further drive the company's focus on customers and patients and accelerate its growth strategy.
BLOOMFIELD, Conn., Feb. 26, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Brian Evanko, EVP and CFO of The Cigna Group, and President and CEO of Cigna Healthcare, will present at Barclays 27th Annual Global Healthcare Conference on March 12, 2025, through a virtual webcast. The Cigna Group's presentation is expected to begin at approximately 2:00 p.m. ET. A live webcast of the presentation will be available at https://investors.thecignagroup.com/events-and-presentations/default.aspx in the Investor Relations section of The Cigna Grou
Nonprofits are encouraged to apply now for 2025 grantsThe Cigna Group Foundation committed $9 million in 2024 to address youth mental health, distributing $3 million each year through 2026In first year, 28 grantees were awarded funding to expand programs, including youth camps, mindfulness coach program and conflict resolution techniquesBLOOMFIELD, Conn., Feb. 12, 2025 /PRNewswire/ -- The Cigna Group Foundation, the philanthropic arm of The Cigna Group (NYSE:CI), announced today it is taking further actions to combat the youth mental health crisis sweeping the nation. As part of a $9 million, three-year commitment that began in 2024, the Foundation has opened its second year of funding and w
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
4 - Cigna Group (0001739940) (Issuer)
144 - Cigna Group (0001739940) (Subject)
144 - Cigna Group (0001739940) (Subject)
144 - Cigna Group (0001739940) (Subject)
144 - Cigna Group (0001739940) (Subject)
10-Q - Cigna Group (0001739940) (Filer)
8-K - Cigna Group (0001739940) (Filer)
SCHEDULE 13G/A - Cigna Group (0001739940) (Subject)
8-K - Cigna Group (0001739940) (Filer)
8-K - Cigna Group (0001739940) (Filer)
144 - Cigna Group (0001739940) (Subject)
Bernstein downgraded The Cigna Group from Outperform to Mkt Perform and set a new price target of $323.00
Piper Sandler initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $400.00
Robert W. Baird initiated coverage of The Cigna Group with a rating of Outperform and set a new price target of $388.00
Barclays initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $393.00
Cantor Fitzgerald upgraded The Cigna Group from Neutral to Overweight and set a new price target of $372.00 from $334.00 previously
RBC Capital Mkts upgraded The Cigna Group from Sector Perform to Outperform and set a new price target of $354.00 from $327.00 previously
Deutsche Bank upgraded The Cigna Group from Hold to Buy and set a new price target of $370.00 from $355.00 previously
Bernstein upgraded The Cigna Group from Mkt Perform to Outperform and set a new price target of $372.00 from $330.00 previously
Jefferies upgraded The Cigna Group from Hold to Buy and set a new price target of $341.00 from $335.00 previously
Edward Jones downgraded The Cigna Group from Buy to Hold
As part of the company's initiative, thousands of employees logged 280,000 minutes of exercise over nine days Cigna leaders biked to Hartford, Conn.'s Dunkin' Park to host Boys & Girls Clubs members for a Yard Goats baseball game, with surprise appearances by UConn basketball coach and playersBLOOMFIELD, Conn., Sept. 9, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI) put out a challenge to its workforce this summer, inviting colleagues to join its first-ever Community Vitality Project, a nine-day challenge combining fun, fitness and fundraising. By logging more than 280,000 minutes of fitness activities and awarding their minutes spent moving, The Cigna Group employees helped determine how to
Brian Evanko to continue as Chief Financial Officer, will serve as new President and CEO of Cigna HealthcareAnn Dennison to join The Cigna Group as Deputy Chief Financial OfficerMike Triplett to retire by end of 2024 and Bryan Holgerson promoted to President of U.S. Commercial for Cigna HealthcareEric Palmer to assume expanded role leading enterprise strategy and corporate development, will continue as President and CEO of Evernorth Health ServicesBLOOMFIELD, Conn., Jan. 17, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI), a global health company, today announced leadership changes designed to continue accelerating growth across Evernorth Health Services and Cigna Healthcare.
BLOOMFIELD, Conn., May 1, 2023 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023. CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023." alt="The Cigna Group (NYSE:CI) today announced that Dr. Philip Ozuah has been appointed to the organization's Board of Directors. His appointment is effective June 1, 2023."> Since 2019, Dr. Philip Oz
Group Believes Board Has Disregarded Shareholders' Concerns by Appointing Solomon Trujillo as "Independent" Chairman Highlights Conflicting Financial Arrangements and Interlocks Among Board Members, Including Mr. Trujillo and Chief Executive Officer Marlow Hernandez Reiterates Demand that the Board Respect the Wishes of Shareholders by Making Necessary Leadership Changes or Reopening the Window to Nominate Director Candidates and Submit Proposals at 2023 Annual Meeting Elliot Cooperstone, Lewis Gold and Barry Sternlicht (collectively with certain of their affiliates, the "Group" or "we"), who recently resigned as members of the Board of Directors (the "Board") of Cano Health, Inc. ("C
PAVmed Inc. (NASDAQ:PAVM, PAVMZ))) (the "Company" or "PAVmed"), a diversified commercial-stage medical technology company and parent of cancer prevention company Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid"), today announced the appointment of prominent healthcare services industry leader and president of Care Solutions for Evernorth, Joan Harvey, to its Board of Directors. Ms. Harvey will serve as a member of the Company's Audit and Compensation Committees. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220215005417/en/PAVmed appoints Joan Harvey to its Board of Directors. (Photo: Business Wire) "Ms. Harvey brings a wealth of h
Better Therapeutics, Inc. (("Better Therapeutics", NASDAQ:BTTX), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, today announced the appointment of Major General Elder Granger, M.D., U.S. Army (retired) to its board of directors. "Dr. Granger's track record of leadership in navigating complex policy, regulatory and competitive environments will be welcome additions to the Better Therapeutics board," said David Perry, co-founder and chairman of Better Therapeutics. "His extensive board experience coupled with an unwavering commitment to improving the delivery of healthcare will be invaluable as we wo
BLOOMFIELD, Conn., July 30, 2021 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) today announced several updates to its Board of Directors. Isaiah Harris, Jr., Chair of the Board of Directors, informed that Company that he intends to retire at the end of the year. Mr. Harris was appointed to the Board in 2005 and has served as Chair since 2009. During this time, Cigna significantly strengthened its core businesses, expanded its capabilities, and accelerated its growth plans, as the organization now serves more than 190 million customer relationships
BLOOMFIELD, Conn., Jan. 12, 2021 /PRNewswire/ -- Global health service company Cigna Corporation (NYSE:CI) today announced that George Kurian has been appointed to Cigna's Board of Directors. His appointment is effective March 1, 2021. Mr. Kurian currently serves as chief executive officer of NetApp, Inc., a cloud-led, data-centric, software company. Prior to joining NetApp in 2011, he served as vice president and general manager of Application Networking and Switching Technology at Cisco Systems. An engineer by training, Mr. Kurian has also previously held product strategy and consulting roles at Akamai Technologies, McKinsey & Company and Oracle Corporation. "With a wealth of product
BLOOMFIELD, Conn., Jan. 6, 2021 /PRNewswire/ -- Global health services company Cigna Corporation (NYSE: CI) today announced that its Board of Directors has instituted a quarterly cash dividend and declared the first quarterly cash dividend of $1.00 per share of Cigna common stock to be paid on March 25, 2021 to shareholders of record as of the close of trading on March 10, 2021. "Cigna has a long track record of effective capital deployment, and our initiation of a quarterly dividend demonstrates our confidence in our ongoing ability to drive growth as we meet the needs of those we serve," said David M. Cordani, president and chief executive officer. "We are excited to share more at our
SC 13G - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Group (0001739940) (Subject)
SC 13G/A - Cigna Corp (0001739940) (Subject)
SC 13G - Cigna Corp (0001739940) (Subject)
SC 13G - Cigna Corp (0001739940) (Subject)
SC 13G/A - Cigna Corp (0001739940) (Subject)